Here's Why You Should Add Lantheus (LNTH) to Your Portfolio Now

Lantheus Holdings, Inc. (LNTH) has been gaining from its focus on pipeline development. The optimism, led by a solid first-quarter 2024 performance and strength in radiopharmaceuticals, is expected to contribute further. However, the company's dependence on third parties and macroeconomic concerns are major downsides. Over the past year, the Zacks Rank #2 (Buy) stock has lost 7.9% against the 2.9% growth of the industry. The S&P 500 has witnessed 26% growth in the said time frame. The renowned radiopharmace ...